fda_endometriosis_drug_81700.jpg - Higher Ground Times

This undated image provided by AbbVie in July 2018 shows packaging for the company's drug Orilissa (elagolix). On Tuesday, July 24, 2018, the company said that The Food and Drug Administration approved its the drug for pain during menstruation and at other times. (AbbVie via AP)

Featured Photo Galleries

Capitals beat Panthers 4-1 as Florida loses 6th out of 7

Commanders lose 3rd in a row, 34-26 to the Cowboys

Trump Transition: Here are the people Trump has picked for key positions so far

President-elect Donald Trump has announced a flurry of picks for his incoming administration. Get full coverage of the Trump transition from The Washingon Times.

Trump dances onstage, takes post-election nation by storm

President-elect Trump dances onstage

Pilots still want to fly the Osprey despite safety issues

The White House's Christmas tree is a symbol of resilience for hurricane-hit North Carolina farms

Southern California wildfire destroys 132 structures as officials look for fierce winds to subside

Ovechkin scoring another game-winning goal for the Capitals comes as no surprise to the Predators

Trump wins the White House in political comeback

U.Ss Election 2024: America Votes

After all the talk, Election Day voting is going mostly smoothly

Jayden Daniels leads Commanders to 27-22 win over Giants for their best start since 1996